A detailed history of Householder Group Estate & Retirement Specialist, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Householder Group Estate & Retirement Specialist, LLC holds 12 shares of VRTX stock, worth $5,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 17 29.41%
Holding current value
$5,643
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$407.69 - $446.08 $2,038 - $2,230
-5 Reduced 29.41%
12 $5,000
Q4 2023

Jan 23, 2024

SELL
$343.0 - $410.68 $5,831 - $6,981
-17 Reduced 50.0%
17 $6,000
Q4 2022

Jan 19, 2023

BUY
$285.76 - $321.48 $285 - $321
1 Added 3.03%
34 $9,000
Q3 2022

Oct 11, 2022

BUY
$273.83 - $305.53 $9,036 - $10,082
33 New
33 $9,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Householder Group Estate & Retirement Specialist, LLC Portfolio

Follow Householder Group Estate & Retirement Specialist, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Householder Group Estate & Retirement Specialist, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Householder Group Estate & Retirement Specialist, LLC with notifications on news.